Determining the extent and stage of disease in patients with newly diagnosed non-Hodgkin?s lymphoma using 18F-FDG-PET/CT

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F11%3A00052521" target="_blank" >RIV/00216224:14110/11:00052521 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/11:11010 RIV/61989592:15110/11:33115933 RIV/00064165:_____/11:11010
Result on the web
<a href="http://dx.doi.org/10.4149/neo_2011_04_291" target="_blank" >http://dx.doi.org/10.4149/neo_2011_04_291</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.4149/neo_2011_04_291" target="_blank" >10.4149/neo_2011_04_291</a>

Result language
angličtina
Original language name
Determining the extent and stage of disease in patients with newly diagnosed non-Hodgkin?s lymphoma using 18F-FDG-PET/CT
Original language description
Positron emission tomography (PET) using 2-[fluorine-18]-fluoro-2-deoxy-D-glucose (18F-FDG) combined with computed tomography (CT) represents a three-dimensional imaging method suitable for staging in patients with non-Hodgkin?s lymphomas (NHLs). The aimof our prospective multicenter study was to assess the value of initial PET/CT as compared with CT and PET alone for determining the stage and extent of the disease. A total of 122 patients with newly diagnosed NHL were examined using PET/CT. Four patients with resected lymphoma lesion and negative PET/CT were therefore excluded from the study. Of the remaining 118 cases, a total of 117 (99%) were described as 18F-FDG-avid. When compared with PET/CT, CT and PET showed very good sensitivity of lymph node imaging (97% and 100%, respectively); the specificity, however, was significantly lower (66.7% and 94.4%, respectively; p=0.0001). When detecting organ lesions, the sensitivity of CT and PET was lower than that of PET/CT (92.5% and 96.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—

Project
<a href="/en/project/NR9502" target="_blank" >NR9502: Integrated 2-[fluorine-18] fluoro-2-deoxy-D-glucose positron emission tomography with computer tomography as basic imaging method for the evaluation of non-Hodgkin´s lymphoma patients</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2011
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)